By Dr Nicola Davies
Labeling information, including product inserts, are important components of marketed drug products. Clear and complete labeling information is critical for both health professionals and patients to make informed decisions. It also ensures consumers are aware of the correct use of these medications to maintain safety and achieve the intended effectiveness. The importance of appropriate labeling information is highlighted by the US Food and Drug Administration’s recent actions to optimize labeling content for prescription drugs, including biologicals.
Action by the FDA
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze